Investor FAQs | Sensei Biotherapeutics, Inc

Where is Sensei headquartered?

The Company has locations at 1405 Research Blvd, Suite 125, Rockville, MD 20850 and 451 D St, Unit 906, Boston, MA 02210. The main office number is 240-243-8000.

When and Where was Sensei incorporated?

Sensei was incorporated in Delaware in 2017.

On which stock exchange are Sensei shares being traded and what is the ticker symbol?

Shares of Sensei are traded on the NASDAQ Capital Market under the ticker symbol SNSE. The CUSIP number is 81728A1207

When is Sensei’s fiscal year-end?

Sensei’s fiscal year ends on December 31st.

When was Sensei’s IPO?

Sensei began trading on the NASDAQ Global Market on February 4, 2021.

Who is Sensei’s transfer agent?

Sensei’s transfer agent is Equiniti Trust Company, LLC.

How can I purchase shares of Sensei?

Shares can be purchased through a stockbroker of your choice. Sensei does not currently have a direct stock purchase plan.

Does Sensei have a dividend reinvestment program?

Sensei does not currently pay a dividend or offer a dividend reinvestment program.

Who is Sensei’s independent registered public accountant?

Sensei’s independent registered public accountant is Deloitte & Touche LLP, 500 East Pratt Street, Suite 500, Baltimore, MD 21202.

Where can I view Sensei’s latest corporate news and financial reports?

Corporate news can be found in the News & Events section of Sensei’s Investors website. Quarterly and annual reports, as well as other SEC filings, can be found in the SEC filings section of the Investors website or directly from the SEC at www.sec.gov.

Who can I contact for additional questions or requests?

Please contact ir@senseibio.com with any additional inquiries.